Code | 7585E | ||||||||||
MA number | EU/1/12/793/006 | ||||||||||
Product Form: | gra cps 60x20 mg (fľ.HDPE) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 23.10.2012 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHPC XALKORI.pdf |
Safety feature | Yes |
Data update: | 20.09.2024 |